| 前收盘价格 | 74.15 |
| 收盘价格 | 74.16 |
| 成交量 | 4,671,487 |
| 平均成交量 (3个月) | 2,829,144 |
| 市值 | 16,492,178,432 |
| 市盈率 (P/E TTM) | 29.76 |
| 预期市盈率 (P/E Forward) | 16.39 |
| 价格/销量 (P/S) | 4.15 |
| 股市价格/股市净资产 (P/B) | 3.31 |
| 52周波幅 | |
| 利润日期 | 3 Nov 2025 |
| 营业毛利率 | 13.83% |
| 营业利益率 (TTM) | 22.17% |
| 稀释每股收益 (EPS TTM) | 2.38 |
| 季度收入增长率 (YOY) | -1.20% |
| 季度盈利增长率 (YOY) | -18.50% |
| 总债务/股东权益 (D/E MRQ) | 54.80% |
| 流动比率 (MRQ) | 3.24 |
| 营业现金流 (OCF TTM) | 1.13 B |
| 杠杆自由现金流 (LFCF TTM) | 775.88 M |
| 资产报酬率 (ROA TTM) | 6.92% |
| 股东权益报酬率 (ROE TTM) | 11.77% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Instruments & Supplies (US) | 看涨 | 混合的 |
| Medical Instruments & Supplies (全球的) | 混合的 | 看跌 | |
| 股票 | Hologic, Inc. | 看涨 | 看跌 |
AIStockmoo 评分
0.9
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | -1.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 平均 | 0.88 |
|
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts. |
|
| 部门 | Healthcare |
| 行业 | Medical Instruments & Supplies |
| 投资方式 | Mid Core |
| 内部持股比例 | 0.86% |
| 机构持股比例 | 102.61% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 90.00 (Argus Research, 21.46%) | 购买 |
| 中 | 78.00 (5.26%) | |
| 低 | 76.00 (Morgan Stanley, 2.56%) | 保留 |
| 76.00 (Stephens & Co., 2.56%) | 保留 | |
| 平均值 | 79.14 (6.80%) | |
| 总计 | 2 购买, 5 保留 | |
| 平均价格@调整类型 | 72.06 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Morgan Stanley | 11 Nov 2025 | 76.00 (2.56%) | 保留 | 74.60 |
| Mizuho | 23 Oct 2025 | 78.00 (5.26%) | 保留 | 73.89 |
| JP Morgan | 22 Oct 2025 | 78.00 (5.26%) | 保留 | 73.93 |
| Stephens & Co. | 22 Oct 2025 | 76.00 (2.56%) | 保留 | 73.93 |
| 18 Sep 2025 | 78.00 (5.26%) | 购买 | 68.27 | |
| Leerink Partners | 21 Oct 2025 | 78.00 (5.26%) | 保留 | 73.98 |
| Evercore ISI Group | 07 Oct 2025 | 78.00 (5.26%) | 购买 | 67.73 |
| Argus Research | 19 Sep 2025 | 90.00 (21.46%) | 购买 | 66.33 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合